Literature DB >> 4139277

HL-A expression on the G1, S, and G2 cell-cycle stages of human lymphoid cells.

L K Everson, B A Plocinik, G N Rogentine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4139277     DOI: 10.1093/jnci/53.4.913

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  8 in total

1.  Time-dependent resistance or susceptibility of tumor cells to cytotoxic antibody after exposure to a chemotherapeutic agent.

Authors:  P J Leibson; H Schreiber; M R Loken; S Panem; D A Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

2.  Mechanisms of complement resistance induced by non-lethal complement attack and by growth arrest.

Authors:  K J Marchbank; C W van den Berg; B P Morgan
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

3.  Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle.

Authors:  S P Leong; P D Noguchi; R E Cunningham; T Takami; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Tumor heterogeneity: biological implications and therapeutic consequences.

Authors:  G H Heppner; B E Miller
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 5.  Intratumor immunologic heterogeneity.

Authors:  F R Miller
Journal:  Cancer Metastasis Rev       Date:  1982       Impact factor: 9.264

6.  Cytolytic T lymphocyte function is independent of growth phase and position in the mitotic cycle.

Authors:  R P Sekaly; H R MacDonald; P Zaech; A L Glasebrook; J C Cerottini
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

7.  Cell cycle-associated changes in receptors for IgE during growth and differentiation of a rat basophilic leukemia cell line.

Authors:  C Isersky; H Metzger; D N Buell
Journal:  J Exp Med       Date:  1975-05-01       Impact factor: 14.307

8.  Growth properties and alloantigenic expression of murine lymphoblastoid cell lines.

Authors:  R K Zwerner; R T Acton
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.